AU2001288853A1 - Methods of detecting cancer based on prostasin - Google Patents

Methods of detecting cancer based on prostasin

Info

Publication number
AU2001288853A1
AU2001288853A1 AU2001288853A AU8885301A AU2001288853A1 AU 2001288853 A1 AU2001288853 A1 AU 2001288853A1 AU 2001288853 A AU2001288853 A AU 2001288853A AU 8885301 A AU8885301 A AU 8885301A AU 2001288853 A1 AU2001288853 A1 AU 2001288853A1
Authority
AU
Australia
Prior art keywords
prostasin
methods
detecting cancer
cancer based
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288853A
Inventor
Samuel C. Mok
Kwong-Kwok Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2001288853A1 publication Critical patent/AU2001288853A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
AU2001288853A 2000-09-07 2001-09-07 Methods of detecting cancer based on prostasin Abandoned AU2001288853A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23116600P 2000-09-07 2000-09-07
US60/231,166 2000-09-07
PCT/US2001/027718 WO2002021133A2 (en) 2000-09-07 2001-09-07 Methods of detecting cancer based on prostasin

Publications (1)

Publication Number Publication Date
AU2001288853A1 true AU2001288853A1 (en) 2002-03-22

Family

ID=22868012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288853A Abandoned AU2001288853A1 (en) 2000-09-07 2001-09-07 Methods of detecting cancer based on prostasin

Country Status (3)

Country Link
US (2) US6846642B2 (en)
AU (1) AU2001288853A1 (en)
WO (1) WO2002021133A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
AT412026B (en) * 2002-02-07 2004-08-26 Illmensee Karl Dr METHOD FOR DIAGNOSING A CYSTIC OVARIAL CARCINOMA
US7745180B2 (en) * 2002-04-24 2010-06-29 Hitachi Chemical Co., Ltd. Device and method for high-throughput quantification of mRNA from whole blood
CN101692090B (en) * 2002-08-06 2014-06-25 约翰霍普金斯大学 Use of biomarkers for detecting ovarian cancer
WO2004106536A2 (en) * 2003-05-28 2004-12-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with serine protease 8 (prss8)
WO2005008247A2 (en) * 2003-07-11 2005-01-27 Science & Technology Corporation @ Unm. Detection of endometrial pathology
US20050277137A1 (en) * 2003-08-15 2005-12-15 University Of Pittsburgh Diagnostic multimarker serological profiling
US20070042405A1 (en) * 2003-08-15 2007-02-22 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Enhanced diagnostic multimarker serological profiling
CA2535805A1 (en) * 2003-08-15 2005-02-24 University Of Pittsburgh Of The Commnonwealth System Of Higher Education Multifactorial assay for cancer detection
KR100536461B1 (en) * 2003-09-16 2005-12-14 주식회사 정우인터내셔날 Micro-dissection system
US20070122856A1 (en) * 2005-11-10 2007-05-31 Aurelium Biopharma Inc. Tissue diagnostics for ovarian cancer
JP4829961B2 (en) * 2006-05-01 2011-12-07 日立化成工業株式会社 Prostasin partial peptide and anti-prostasin antibody
WO2007134262A2 (en) * 2006-05-11 2007-11-22 Irm Llc Crystal structure of prostasin and uses thereof
WO2007149948A2 (en) * 2006-06-20 2007-12-27 The Gov. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for diagnosis and treatment of tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604106A (en) * 1987-06-05 1997-02-18 Us Commerce Method for detecting carcinoma
US5695761A (en) * 1993-12-23 1997-12-09 Rutgers University Suppression of nitric oxide production by osteopontin
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
EP0920452A1 (en) * 1996-08-22 1999-06-09 Children's Medical Center Corporation Novel osteopontin derived chemotactic peptides and methods of use
US5928883A (en) * 1996-11-13 1999-07-27 Mayo Foundation For Medical Education Eosinophil granole proteins as indicators of inflammatory bowel disorders
US5801004A (en) * 1996-12-23 1998-09-01 Hudson; Perry B. Method for detecting prostatic cancer
US5866119A (en) * 1997-06-02 1999-02-02 Incyte Pharmaceuticals, Inc. Human ribonuclease
US6414219B1 (en) * 1998-06-30 2002-07-02 Rutgers, The State University Of New Jersey Osteopontin knock-out mouse and methods of use thereof
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
US6569684B2 (en) * 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
WO2002042733A2 (en) 2000-11-16 2002-05-30 Ciphergen Biosystems, Inc. Method for analyzing mass spectra
WO2002071928A2 (en) 2001-03-14 2002-09-19 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

Also Published As

Publication number Publication date
US20050095642A1 (en) 2005-05-05
US20020090625A1 (en) 2002-07-11
WO2002021133A3 (en) 2003-02-27
US7214501B2 (en) 2007-05-08
US6846642B2 (en) 2005-01-25
WO2002021133A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001294989A1 (en) Speech detection
AU2001293998A1 (en) Detection system
AU2002225807A1 (en) Object detection
AU2001268484A1 (en) Gps enabled speeding detector
AU2001250941A1 (en) Location determination using rf fingerprinting
AU2002220234A1 (en) Single user detection
AU2001288268A1 (en) Near object detection system
AU2002220898A1 (en) Ligand detection method
AU2001296554A1 (en) Fluorescence detection
AU2001280599A1 (en) Compounds and methods
AU2001251414A1 (en) Method of detecting carcinomas
AU2001288853A1 (en) Methods of detecting cancer based on prostasin
AU2001290860A1 (en) Spas-1 cancer antigen
AU2001238412A1 (en) Reaction and separation methods
AU2001281633A1 (en) Detection method
AUPR050700A0 (en) Detection method
AUPQ667800A0 (en) Detection method
AUPQ872300A0 (en) Compounds and methods
AU5867901A (en) Method for detecting tumors
AUPQ609000A0 (en) Commercial detector
AU2001278951A1 (en) Compounds and methods
AU2001246862A1 (en) Method of detecting cancer
AU2002231008A1 (en) Free analyte detection system
AU2001271033A1 (en) Means of assaying immune function
AU2002366141A1 (en) Method of detecting malignant tumor and detection kit